Asia FX weakens slightly, rupee recovers from record low as RBI holds rates
Investing.com - DA Davidson raised its price target on Standex International (NYSE:SXI) to $219.00 from $200.00 while maintaining a Buy rating following the company’s fiscal fourth-quarter 2025 earnings report. The stock, which has surged nearly 10% in the past week, is currently trading at a P/E multiple of 39.5x. According to InvestingPro analysis, the stock appears to be trading above its Fair Value.
The firm cited Standex’s potential to break a nearly two-year streak of quarterly organic revenue declines, noting this reversal could happen "in a big way."
DA Davidson highlighted that Standex appears positioned for significant revenue growth of over $100 million in fiscal year 2025, combining both organic growth and acquisitions.
The research firm also pointed to Standex’s decision to provide a full-year outlook rather than just quarterly guidance as evidence of strong visibility into its business performance.
DA Davidson continues to recommend Standex as a "solid SMidcap growth idea" for investors based on these positive indicators.
In other recent news, Standex International reported strong fourth-quarter 2025 earnings, surpassing market expectations. The company posted an earnings per share (EPS) of $2.28, outperforming the forecast of $2.10, which represents an 8.57% surprise. Revenue also exceeded projections, reaching $222 million, compared to the expected $214.44 million. Standex achieved a 23% year-over-year sales growth and expanded its adjusted EBITDA margins by 350 basis points. Following these results, Roth/MKM raised its price target for Standex International to $205 from $175, maintaining a Buy rating. The firm’s decision reflects confidence in the company’s strong performance. These developments indicate positive momentum for Standex International, capturing the attention of investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.